Literature DB >> 36201016

NODDI, diffusion tensor microstructural abnormalities and atrophy of brain white matter and gray matter contribute to cognitive impairment in multiple sclerosis.

Paolo Preziosa1,2,3, Elisabetta Pagani1, Alessandro Meani1, Olga Marchesi1, Lorenzo Conti1, Andrea Falini4,3, Maria A Rocca1,2,3, Massimo Filippi5,6,7,8,9.   

Abstract

BACKGROUND: Pathologically specific MRI measures may elucidate in-vivo the heterogeneous processes contributing to cognitive impairment in multiple sclerosis (MS).
PURPOSE: Using diffusion tensor and neurite orientation dispersion and density imaging (NODDI), we explored the contribution of focal lesions and normal-appearing (NA) tissue microstructural abnormalities to cognitive impairment in MS.
METHODS: One hundred and fifty-two MS patients underwent 3 T brain MRI and a neuropsychological evaluation. Forty-eight healthy controls (HC) were also scanned. Fractional anisotropy (FA), mean diffusivity (MD), intracellular volume fraction (ICV_f) and orientation dispersion index (ODI) were assessed in cortical and white matter (WM) lesions, thalamus, NA cortex and NAWM. Predictors of cognitive impairment were identified using random forest.
RESULTS: Fifty-two MS patients were cognitively impaired. Compared to cognitively preserved, impaired MS patients had higher WM lesion volume (LV), lower normalized brain volume (NBV), cortical volume (NCV), thalamic volume (NTV), and WM volume (p ≤ 0.021). They also showed lower NAWM FA, higher NAWM, NA cortex and thalamic MD, lower NAWM ICV_f, lower WM lesion ODI, and higher NAWM ODI (false discovery rate-p ≤ 0.026). Cortical lesion number and microstructural abnormalities were not significantly different. The best MRI predictors of cognitive impairment (relative importance) (out-of-bag area under the curve = 0.727) were NAWM FA (100%), NTV (96.0%), NBV (84.7%), thalamic MD (43.4%), NCV (40.6%), NA cortex MD (26.0%), WM LV (23.2%) and WM lesion ODI (17.9%).
CONCLUSIONS: Our multiparametric MRI study including NODDI measures suggested that neuro-axonal damage and loss of microarchitecture integrity in focal WM lesions, NAWM, and GM contribute to cognitive impairment in MS.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Cognitive impairment; GM atrophy; MRI; Multiple sclerosis; NODDI

Year:  2022        PMID: 36201016     DOI: 10.1007/s00415-022-11415-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   6.682


  48 in total

Review 1.  Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis.

Authors:  Maria A Rocca; Maria P Amato; Nicola De Stefano; Christian Enzinger; Jeroen J Geurts; Iris-K Penner; Alex Rovira; James F Sumowski; Paola Valsasina; Massimo Filippi
Journal:  Lancet Neurol       Date:  2015-02-04       Impact factor: 44.182

2.  Cognitive functions in multiple sclerosis: impact of gray matter integrity.

Authors:  Sara Llufriu; Eloy Martinez-Heras; Juan Fortea; Yolanda Blanco; Joan Berenguer; Iñigo Gabilondo; Naroa Ibarretxe-Bilbao; Carles Falcon; Maria Sepulveda; Nuria Sola-Valls; Nuria Bargallo; Francesc Graus; Pablo Villoslada; Albert Saiz
Journal:  Mult Scler       Date:  2013-09-04       Impact factor: 6.312

Review 3.  Association between pathological and MRI findings in multiple sclerosis.

Authors:  Massimo Filippi; Wolfgang Brück; Declan Chard; Franz Fazekas; Jeroen J G Geurts; Christian Enzinger; Simon Hametner; Tanja Kuhlmann; Paolo Preziosa; Àlex Rovira; Klaus Schmierer; Christine Stadelmann; Maria A Rocca
Journal:  Lancet Neurol       Date:  2019-02       Impact factor: 44.182

4.  Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosis.

Authors:  S Mesaros; M A Rocca; K Kacar; J Kostic; M Copetti; T Stosic-Opincal; P Preziosa; S Sala; G Riccitelli; M A Horsfield; J Drulovic; G Comi; M Filippi
Journal:  Neurology       Date:  2012-02-29       Impact factor: 9.910

5.  Determinants of Cognitive Impairment in Patients with Multiple Sclerosis with and without Atrophy.

Authors:  Anand J C Eijlers; Kim A Meijer; Quinten van Geest; Jeroen J G Geurts; Menno M Schoonheim
Journal:  Radiology       Date:  2018-05-22       Impact factor: 11.105

6.  Cognitive impairment in benign multiple sclerosis: a multiparametric structural and functional MRI study.

Authors:  Gianna C Riccitelli; Elisabetta Pagani; Alessandro Meani; Paola Valsasina; Paolo Preziosa; Massimo Filippi; Maria A Rocca
Journal:  J Neurol       Date:  2020-07-02       Impact factor: 4.849

7.  Unraveling the substrates of cognitive impairment in multiple sclerosis: A multiparametric structural and functional MRI study.

Authors:  Lorenzo Conti; Paolo Preziosa; Alessandro Meani; Elisabetta Pagani; Paola Valsasina; Olga Marchesi; Carmen Vizzino; Maria A Rocca; Massimo Filippi
Journal:  Eur J Neurol       Date:  2021-07-13       Impact factor: 6.089

8.  Cognitive impairment in MS: impact of white matter integrity, gray matter volume, and lesions.

Authors:  Hanneke E Hulst; Martijn D Steenwijk; Adriaan Versteeg; Petra J W Pouwels; Hugo Vrenken; Bernard M J Uitdehaag; Chris H Polman; Jeroen J G Geurts; Frederik Barkhof
Journal:  Neurology       Date:  2013-03-06       Impact factor: 9.910

9.  Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.

Authors:  Paolo Preziosa; Maria A Rocca; Elisabetta Pagani; Maria Laura Stromillo; Christian Enzinger; Antonio Gallo; Hanneke E Hulst; Matteo Atzori; Deborah Pareto; Gianna C Riccitelli; Massimiliano Copetti; Nicola De Stefano; Franz Fazekas; Alvino Bisecco; Frederik Barkhof; Tarek A Yousry; Maria J Arévalo; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2016-02-02       Impact factor: 5.038

10.  Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology?

Authors:  Francesco Grussu; Torben Schneider; Carmen Tur; Richard L Yates; Mohamed Tachrount; Andrada Ianuş; Marios C Yiannakas; Jia Newcombe; Hui Zhang; Daniel C Alexander; Gabriele C DeLuca; Claudia A M Gandini Wheeler-Kingshott
Journal:  Ann Clin Transl Neurol       Date:  2017-08-15       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.